From Radar on Drug Benefits - The CEO of Harvard Pilgrim Health Care recently posited that Narcan (naloxone), an opiate antidote, should be as readily available as fire extinguishers or defibrillators in the workplace. As health insurers seek ways to address the U.S. opioid crisis, the Trump administration is putting significant weight on the regulatory side.
CMS on April 2 finalized new policies in its 2019 Rate Announcement and Final Call Letter for Medicare Advantage (MA) and Part D plans that continue to focus heavily on ways to monitor and decrease opioid misuse.
Read more